|
Buckeye
Pharmaceuticals
is exploiting
our proprietary
technologies to
enhance the
delivery of
localized
pharmaceuticals
through
membranes such
as skin, nail,
eyelid or rectal
wall.
Treatments will
take place in
physicians’
office as a
reimbursable
medical
procedure with
Buckeye
merchandising
the equipment,
the disposable
electrode and
eventually the
proprietary
pharmaceutical.
In contrast to
traditional
topical drug
delivery
technologies
that create a
bolus of drug on
the surface of
the skin and
rely on passive
diffusion for
delivery,
Buckeye’s
MACROESISTM
drives a the drug
into the skin,
creating an intradermal drug
depot. The
technology
provides unique
convenience and
control to the
patient and/or
physician,
enabling
painless
treatment for a
variety of
dermatologic
conditions.
Buckeye's
MACROESISTM
technology
is being
employed to
create a rich
pipeline of
potential
products.
Our initial
focus is on
onychomycosis,
but promising
future
applications are
being examined
including
herpes labialis,
catheter
infections,
psychotropic
diseases,
actinic
keratosis,
acne,
psoriasis, and
derma filler
wrinkles.
Our spin-off
company, Buckeye
Ocular, is
exploring
possibilities
for applying
MACROESISTM
to age-related
macular
degeneration. |
